Jinsong Gu

Prof. Dr. Jinsong Gu


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Analytica Chimica Acta
Verified
Journal Article
Closed access
XQXueying Qiao
Xueying Qiao
FXFangquan Xia
Fangquan Xia
DTDong Tian
Dong Tian
PCPeipei Chen
Peipei Chen
JLJianhui Liu
Jianhui Liu
CZChangli Zhou
Changli Zhou

29 May 2023 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
XZXiaodong Zhao
Xiaodong Zhao
MKMengmeng Kong
Mengmeng Kong
YWYilin Wang
Yilin Wang
YMYingxin Mao
Yingxin Mao
HXHUI-LIAN XU
HUI-LIAN XU
JGJinsong Gu
Jinsong Gu

13 September 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
YLYuan Li
Yuan Li
MWMengyao Wu
Mengyao Wu
MKMengmeng Kong
Mengmeng Kong
SSShaomei Sui
Shaomei Sui
QWQi Wang
Qi Wang
JGJinsong Gu
Jinsong Gu
Based on published information, the occurrence and development of Alzheimer’s disease (AD) are potentially related to gut microbiota changes. Donepezil hydrochloride (DH), which enhances cholinergic activity by blocking acetylcholinesterase (AChE), is one of the first-line drugs for AD treatment approved by the Food and Drug Administration (FDA) of the USA. However, the potential link between the effects of DH on the pathophysiological processes of AD and the gut microbiota remains unclear. In this study, pathological changes in the brain and colon, the activities of superoxide dismutase (SOD) and AChE, and changes in intestinal flora were observed. The results showed that Aβ deposition in the prefrontal cortex and hippocampus of AD mice was significantly decreased, while colonic inflammation was significantly alleviated by DH treatment. Concomitantly, SOD activity was significantly improved, while AChE was significantly reduced after DH administration. In addition, the gut microbiota community composition of AD mice was significantly altered after DH treatment. The relative abundance of Akkermansia in the AD group was 54.8% higher than that in the N group. The relative abundance of Akkermansia was increased by 18.3% and 53.8% in the AD_G group and the N_G group, respectively. Interestingly, Akkermansia showed a potential predictive value and might be a biomarker for AD. Molecular docking revealed the binding mode and major forces between DH and membrane proteins of Akkermansia. The overall results suggest a novel therapeutic mechanism for treating AD and highlight the critical role of gut microbiota in AD pathology.

1 July 2017 in Microbial Pathogenesis
Verified
Journal Article
Closed access
THTian Han
Tian Han
YLYanhua Li
Yanhua Li
QSQiuli Shan
Qiuli Shan
WLWenjing Liang
Wenjing Liang
WHWeiwei Hao
Weiwei Hao
JGJinsong Gu
Jinsong Gu

17 June 2024 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JZJianing Zhang
Jianing Zhang
XZXiaodong Zhao
Xiaodong Zhao
HXHuilian Xu
Huilian Xu
XLXiaoyong Liu
Xiaoyong Liu
YHYan He
Yan He
JGJinsong Gu
Jinsong Gu

22 July 2024 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
CLCaifeng Li
Caifeng Li
XZXiaodong Zhao
Xiaodong Zhao
HXHuilian Xu
Huilian Xu
XLXiaoyong Liu
Xiaoyong Liu
YHYan He
Yan He
JGJinsong Gu
Jinsong Gu